STRO
Sutro Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.07
−2.29%Leverage
- Debt / equity
- -0.10x
- Net debt / equity
- 0.42x
- Debt / assets
- 0.06x
- Debt / EBITDA
- -0.08x
- Net debt / EBITDA
- 0.32x
Liquidity & coverage
- Current ratio
- 3.32x
- Quick ratio
- 3.32x
- Cash ratio
- 3.11x
- Interest coverage
- -3.53x
- EBITDA / interest
- -3.36x
- Working capital
- $122.7M
Cash & dividend
- FCF / debt
- -13.50x
- Cash flow / debt
- -13.46x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026